Peripheral blood mononuclear cell-derived erythroid progenitors and erythroblasts are decreased in burn patients

Journal of Burn Care and Research

Volumn 34, Issue 1, 2013, Pages 133-141

  Williams, K N ^a   Szilagyi, A ^a   Conrad, P ^a   Halerz, M ^a   Kini, A R ^a   Li, Y ^a   Gamelli, R L ^a   Shankar, R ^a   Muthumalaiappan, K ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD71 ANTIGEN; COLONY STIMULATING FACTOR 1; CYCLOSPORIN A; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; INTERLEUKIN 3; STEM CELL FACTOR;

ADULT; AGED; ANEMIA; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; BURN; BURN PATIENT; CALCULATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DENSITY GRADIENT CENTRIFUGATION; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFORMED CONSENT; LIQUID CULTURE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; ANALYSIS OF VARIANCE; BURNS; CASE-CONTROL STUDIES; CELLS, CULTURED; CYCLOSPORINE; ERYTHROBLASTS; ERYTHROID PRECURSOR CELLS; ERYTHROPOIETIN; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; STEM CELL FACTOR; TRANSFERRIN;

EID: 84873801760     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3182642ccd     Document Type: Article

References (45)

1. Loebl EC, Baxter CR, Curreri PW. The mechanism of erythrocyte destruction in the early post-burn period. Ann Surg 1973;178:681-6.
2. Posluszny JA Jr, Conrad P, Halerz M, Shankar R, Gamelli RL. Classifying transfusions related to the anemia of critical illness in burn patients. J Trauma 2011;71:26-31.
3. Posluszny JA Jr, Gamelli RL. Anemia of thermal injury: combined acute blood loss anemia and anemia of critical illness. J Burn Care Res 2010;31:229-42.
4. Curinga G, Jain A, Feldman M, Prosciak M, Phillips B, Milner S. Red blood cell transfusion following burn. Burns 2011;37:742-52.
5. Waymack JP, Robb E, Alexander JW. Effect of transfusion on immune function in a traumatized animal model. II. Effect on mortality rate following septic challenge. Arch Surg 1987;122:935-9.
6. Greenburg AG. Benefits and risks of blood transfusion in surgical patients. World J Surg 1996;20:1189-93.
7. Valeri CR, Crowley JP, Loscalzo J. The red cell transfusion trigger: has a sin of commission now become a sin of omission Transfusion 1998;38:602-10.
8. Dunne JR, Malone DL, Tracy JK, Napolitano LM. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt) 2004;5:395-404.
9. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003;54:898-905; discussion 905-7.
10. Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL. Transfusion of the injured patient: proceed with caution. Shock 2004;21:291-9.
11. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood 2008;112:2617-26.
12. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012;147:49-55.
13. Graves TA, Cioffi WG, Mason AD Jr, McManus WF, Pruitt BA Jr. Relationship of transfusion and infection in a burn population. J Trauma. 1989;29:948-52; discussion 952-4.
14. Yogore MG 3rd, Boral L, Kowal-Vern A, Patel H, Brown S, Latenser BA. Use of blood bank services in a burn unit. J Burn Care Res 2006;27:835-41.
15. Palmieri TL, Greenhalgh DG. Blood transfusion in burns: what do we do? J Burn Care Rehabil 2004;25:71-5.
16. Deitch EA, Sittig KM. A serial study of the erythropoietic response to thermal injury. Ann Surg 1993;217:293-9.
17. Still JM Jr, Belcher K, Law EJ, et al. A double-blinded prospective evaluation of recombinant human erythropoietin in acutely burned patients. J Trauma 1995;38:233-6.
18. Mittelman M, Lessin LS. Clinical application of recombinant erythropoietin in myelodysplasia. Hematol Oncol Clin North Am 1994;8:993-1009.
19. Kato A, Odamaki M, Takita T, Furuhashi M, Maruyama Y, Hishida A. High blood soluble receptor p80 for tumour necrosis factor-alpha is associated with erythropoietin resistance in haemodialysis patients. Nephrol Dial Transplant 2001;16:1838-44.
20. Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY. Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction. Int J Cardiol 2011
21. Fried W. Erythropoietin and erythropoiesis. Exp Hematol 2009;37:1007-15.
22. Sankaran VG, Orkin SH, Walkley CR. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev 2008;22:463-75.
23. Elliott S, Pham E, Macdougall IC. Erythropoietins: a common mechanism of action. Exp Hematol 2008;36:1573-84.
24. Hattangadi SM, Wong P, Zhang L, Flygare J, Lodish HF. From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 2011;118:6258-68.
25. Posluszny JA Jr, Muthumalaiappan K, Kini AR, et al. Burn injury dampens erythroid cell production through reprioritizing bone marrow hematopoietic response. J Trauma 2011;71:1288-96.
26. Muthumalaiappan K, Szilagyi A, Halerz J. Defective bone marrow erythropoiesis following burn trauma is improved by propranolol treatment. J Leukoc Biol 2011;(Suppl):S39.
27. Livingston DH, Anjaria D, Wu J, et al. Bone marrow failure following severe injury in humans. Ann Surg 2003;238:748-53.
28. Christensen RD, Leckman S, Saffle JR, Rothstein G. Haematopoietic progenitor cells in an infant who developed pancytopenia following an extensive burn. Burns Incl Therm Inj 1988;14:101-6.
29. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science 2001;294:1933-6.
30. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 2003;102: 1249-53.
31. van den Akker E, Satchwell TJ, Pellegrin S, Daniels G, Toye AM. The majority of the in vitro erythroid expansion potential resides in CD34(-) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 2010;95:1594-8.
32. Pope SH, Fibach E, Sun J, Chin K, Rodgers GP. Twophase liquid culture system models normal human adult erythropoiesis at the molecular level. Eur J Haematol 2000;64:292-303.
33. Merryweather-Clarke AT, Atzberger A, Soneji S, et al. Global gene expression analysis of human erythroid progenitors. Blood 2011;117:e96-108.
34. Giarratana MC, Rouard H, Dumont A, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 2011;118:5071-9.
35. Feezor RJ, Baker HV, Mindrinos M, et al; Inflammation and Host Response to Injury, Large-Scale Collaborative Research Program. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004;19:247-54.
36. Laudanski K, Miller-Graziano C, Xiao W, et al. Cell-specific expression and pathway analyses reveal alterations in traumarelated human T cell and monocyte pathways. Proc Natl Acad Sci USA 2006;103:15564-9.
37. Marsee DK, Pinkus GS, Yu H. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Pathol 2010;134:429-35.
38. Dong HY, Wilkes S, Yang H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A. Am J Surg Pathol 2011;35:723-32.
39. Nijhof W, Wierenga PK. Isolation and characterization of the erythroid progenitor cell: CFU-E. J Cell Biol 1983;96:386-92.
40. Bateman AP, McArdle F, Walsh TS. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009;37:1906-12.
41. Wallner SF, Warren GH. The haematopoietic response to burning: an autopsy study. Burns Incl Therm Inj 1985;12:22-7.
42. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995;83:59-67.
43. Howell K, Posluszny J, He LK, et al. High MafB expression following burn augments monocyte commitment and inhibits DC differentiation in hemopoietic progenitors. J Leukoc Biol 2012;91:69-81.
44. Sieweke MH, Tekotte H, Frampton J, Graf T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 1996;85:49-60.
45. Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 1999;31:1111-37.